Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$32,231,874
-$5,001,700 QoQ
Shares Held
1,338,533
+0.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
2.25%
of 13F equity value
Holder Rank
#221
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity & Verity, LLC holds $179,692,626 across 7 Drug Manufacturers - General names. PFE ranks #4 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
178,972 | $45,036,514 | |
| 2 | AMGN |
Amgen Inc
|
104,299 | $37,768,753 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
272,652 | $34,446,853 | |
| 4 | PFE |
Pfizer Inc
This page
|
1,338,533 | $32,231,874 | |
| 5 | JNJ |
Johnson & Johnson
|
115,000 | $29,206,549 | |
| 6 | NVS |
Novartis AG
|
3,453 | $541,154 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,587 | $460,929 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,231,874 | 1,338,533 | Shares | Other | 2026-07-28 | |
| 2026-03-31 | $37,233,574 | 1,325,982 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $32,425,178 | 1,302,216 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $32,722,893 | 1,284,258 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $9,124,008 | 376,403 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $21,995,170 | 868,002 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $16,263,712 | 613,031 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $19,428,984 | 671,354 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $14,858,387 | 531,036 | Shares | Sole | 2024-09-16 | |
| 2024-03-31 | $13,180,278 | 474,965 | Shares | Sole | 2024-09-16 | |
| 2023-12-31 | $5,337,867 | 185,407 | Shares | Sole | 2024-11-07 | |
| 2023-09-30 | $15,001,298 | 452,255 | Shares | Sole | 2024-11-07 | |
| 2023-06-30 | $15,208,261 | 414,620 | Shares | Sole | 2024-11-07 | |
| 2023-03-31 | $15,264,789 | 374,137 | Shares | Sole | 2024-11-07 | |
| 2022-12-31 | $17,942,967 | 350,175 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $14,793,243 | 338,054 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $17,291,466 | 329,801 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $16,968,135 | 327,760 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $19,180,798 | 324,823 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $14,004,787 | 325,617 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $12,509,896 | 319,456 | Shares | Sole | 2021-09-20 | |
| 2021-03-31 | $11,579,687 | 319,616 | Shares | Sole | 2021-06-21 | |
| 2020-12-31 | $10,458,641 | 284,125 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $9,843,077 | 268,204 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $3,530,589 | 107,969 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $3,236,871 | 99,169 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||